NCT00753948View on ClinicalTrials.gov

Exhaled Levels of Nitric Oxide

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
TetraplegiaAsthma
Interventions
DRUG

N-Nitro L-arginine-methylester (L-NAME)

A non-specific inhibitor of the nitric oxide synthase enzyme.

Trial Locations (1)

10468

VA Medical Center, Bronx, The Bronx

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT00753948 - Exhaled Levels of Nitric Oxide | Biotech Hunter | Biotech Hunter